Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

UDG Healthcare acquires market access and HEOR specialist, PHMR Limited, as part of Ashfield Advisory

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Johnson & Johnson to Acquire Atraverse...

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough...

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in...

The U.S. Food and Drug Administration (FDA), through its...

Ashfield Advisory, part of UDG Healthcare plc, announced the acquisition of PHMR Limited, a Market Access Consultancy and specialist in Health Economics and Outcomes Research (HEOR).

Within Ashfield Advisory, PHMR will join forces with Putnam Associates, who specialise in strategy consulting exclusively for the biopharmaceutical and medical device industries. This will strengthen Putnamโ€™s global value, pricing and access practice area by adding complementary HEOR and research science expertise, as well as expanding the companyโ€™s reach in Europe and Japan.

As part of Putnam, PHMR will join Vynamic, STEM Healthcare and SmartAnalyst under the Ashfield Advisory umbrella.

Colin Stanley, Global President of Ashfield Advisory said: โ€œIโ€™m thrilled to announce that PHMR is joining Putnam Associates and the Ashfield Advisory business unit. The PHMR team brings a wealth of experience and trusted expertise that makes them the perfect fit to become a part of both Putnam Associates and our wider Ashfield Advisory offering.

โ€œI look forward to seeing the value both PHMR and Ashfield Advisoryโ€™s existing clients will gain from this acquisition, as it significantly strengthens and expands our existing offering. The additional support we can provide to our clients in Europe and Japan makes this a really exciting time for our business as we continue to experience demand in these major markets.โ€

Founded in 2008, PHMR is headquartered in London with offices in Newcastle, UK and Westport, Ireland. PHMR employs 40 multidisciplinary, highly-qualified team members of health economists and research scientists.

Commenting on the acquisition, Mark Ratcliffe, Founder of PHMR added: โ€œThis acquisition brings great opportunities to both our current and future clients, as weโ€™ll be able to offer the same exceptional service, with the added value of being connected to the Ashfield Advisory ecosystem, as and when our clients need additional support.

โ€œI am extremely proud of the team at PHMR and what we have achieved together. I am very grateful for all their hard work, and I am looking forward to seeing what we can accomplish together as part of the Ashfield Advisory team.โ€

About Ashfield
Ashfield, part of UDG Healthcare plc, is an integrated healthcare services partner, offering a breadth of services across strategic consulting, benchmarking, commercialisation, customer engagement, events, marketing and communications.

Ashfield comprises of three clearly defined, integrated business units: Ashfield Advisory, Ashfield Engage and Ashfield Health. Together, the Ashfield team uses imagination, strategy, and action to redefine and deepen client partnerships, reimagine health and improve lives.

Ashfield has carefully curated its business through the acquisition of 22 companies and is committed to offering streamlined services to best meet its clientsโ€™ needs. With a presence in 50 countries, over 7,000 employees strive to provide best-in-class service for more than 300 clients, including the top 30 global pharmaceutical companies.

About Ashfield Advisory
Ashfield Advisory, part of UDG Healthcare plc, is an ecosystem of connected advisory and consulting businesses including Vynamic, Putnam Associates, STEM Healthcare and SmartAnalyst. All four businesses have specific areas of expertise and are focused on market access and shaping the healthcare industry by hiring top talent, building deep industry expertise, cultivating a boutique approach to client partnerships, and capitalising on the teamโ€™s expansive research and data insights.

Under the Ashfield umbrella, Ashfield Advisory sits alongside Ashfield Engage and Ashfield Health.

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Johnson & Johnson to Acquire Atraverse Medical Platform

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough Medical Device

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in Combination Products

The U.S. Food and Drug Administration (FDA), through its...

FDA 510(k) Clearance Granted to Philips Rembra Platform

Philips has secured FDA 510(k) clearance for its Rembra...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป